Exec Chat: JNJ's Innovation Partnering Strategy Goes Broad And Beyond 'Pinpoint Intervention'
Executive Summary
Medtech's biggest companies are becoming more hands-on in supporting early-stage technologies; their no longer just looking to pick up ready-to-buy assets. Among the most active in this approach is Johnson & Johnson, which has established several vehicles through which it supports and scouts external innovation. Medtech Insight chats with Mirren Mandalia, senior director of new ventures and transactions for medical devices at Johnson & Johnson Innovation, to find out what is driving J&J's technology sourcing strategy and how medtech innovators can work with the diversified health care giant.